awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38016948-A7D7289C-BFF7-4FCF-A3B8-B083977FB8C3
Q38016948-A7D7289C-BFF7-4FCF-A3B8-B083977FB8C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38016948-A7D7289C-BFF7-4FCF-A3B8-B083977FB8C3
A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing.
P2860
Q38016948-A7D7289C-BFF7-4FCF-A3B8-B083977FB8C3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38016948-A7D7289C-BFF7-4FCF-A3B8-B083977FB8C3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a6a41204b738d34165103ba725e7977d75c6e2e0
P2860
A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden.